Form4insider filings, from the source

SEC Form 4 · accession 0001140361-18-022043

Unity Biotechnology, Inc. · UBX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Clinton Bybee
10% Owner
Period of report
May 7, 2018
Accepted (ET)
May 7, 2018 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001463361

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3,F5May 7, 2018C2,030,625—A2,070,172ISee Footnote
Common StockF1,F3,F5May 7, 2018C4,228,432—A6,298,604ISee Footnote
Common StockF1,F3,F5May 7, 2018C2,067,160—A8,365,764ISee Footnote
Common StockF1,F4,F5May 7, 2018C1,486,745—A1,486,745ISee Footnote
Common StockF1,F4,F5May 7, 2018C195,672—A1,682,417ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A-1 Preferred StockF1,F3,F5,F2—May 7, 2018C2,030,625D——Common Stock2,030,6250I
Series A-2 Preferred StockF1,F3,F5,F2—May 7, 2018C4,228,432D——Common Stock4,228,4320I
Series B Preferred StockF1,F3,F5,F2—May 7, 2018C2,067,160D——Common Stock2,067,1600I
Series B Preferred StockF1,F4,F5,F2—May 7, 2018C1,486,745D——Common Stock1,486,7450I
Series C Preferred StockF1,F4,F5,F2—May 7, 2018C195,672D——Common Stock195,6720I

Explanation of responses